Suhayl Dhib-Jalbut Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

5/2009

Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suhayl Dhib-Jalbut Research Topics

Disease

29	Multiple Sclerosis 02/2022 - 04/2002
6	Relapsing-Remitting Multiple Sclerosis 02/2021 - 04/2007
4	Inflammation (Inflammations) 12/2020 - 06/2005
4	Autoimmune Diseases (Autoimmune Disease) 12/2020 - 05/2003
3	Demyelinating Diseases (Demyelinating Disease) 02/2021 - 05/2009
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2014 - 05/2003
3	Disease Progression 01/2014 - 03/2011
2	Hypophosphatemia 02/2022 - 02/2021
2	Infections 01/2021 - 01/2016
2	Neuroinflammatory Diseases 08/2020 - 08/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2016 - 07/2006
1	Leukopenia 02/2022
1	COVID-19 01/2021
1	Stroke (Strokes) 08/2020
1	Dysbiosis 10/2017
1	Menstruation Disturbances 01/2016
1	Virus Diseases (Viral Diseases) 12/2013
1	Neuromyelitis Optica (Devic's Disease) 06/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2009
1	Amyloid Plaque 07/2006
1	Tetanus 07/2003
1	Atrophy 05/2003
1	Nervous System Diseases (Neurological Disorders) 07/2002
1	Central Nervous System Diseases (CNS Diseases) 07/2002
1	Brain Neoplasms (Brain Tumor) 07/2002
1	Viral Encephalitis 07/2002
1	Autoimmune Diseases of the Nervous System 04/2002

Drug/Important Bio-Agent (IBA)

10	Glatiramer Acetate (Copaxone)FDA Link 07/2021 - 04/2002
7	CytokinesIBA 10/2016 - 07/2003
7	Interferon-betaIBA 08/2014 - 07/2002
5	GadoliniumIBA 02/2022 - 05/2003
4	Biomarkers (Surrogate Marker)IBA 08/2014 - 06/2011
4	InterferonsIBA 12/2013 - 04/2002
3	Interferon beta-1b (Betaseron)FDA Link 10/2020 - 01/2012
3	AntigensIBA 01/2014 - 07/2003
2	Gadolinium DTPA (Magnevist)FDA Link 02/2022 - 02/2021
2	Complement C3 (C3 Complement)IBA 02/2021 - 10/2017
2	Dimethyl FumarateIBA 02/2021 - 01/2019
2	Myelin Basic ProteinIBA 12/2020 - 05/2003
2	AutoantigensIBA 10/2017 - 05/2003
2	Pharmaceutical PreparationsIBA 01/2017 - 05/2003
2	ChemokinesIBA 08/2014 - 09/2010
1	Phosphates (Orthophosphate)IBA 02/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020
1	EpitopesIBA 12/2020
1	Dichlororibofuranosylbenzimidazole (DRB)IBA 12/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2020
1	FibrinIBA 08/2020
1	Fibrinogen (Factor I)FDA Link 08/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2017
1	AnaphylatoxinsIBA 10/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2017
1	Hormones (Hormone)IBA 01/2016
1	Estriol (Epiestriol)IBA 01/2016
1	Complement System Proteins (Complement)IBA 08/2014
1	Natalizumab (Tysabri)FDA Link 01/2014
1	Cell Adhesion MoleculesIBA 01/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	HLA-DR Antigens (HLA-DR)IBA 10/2013
1	AntibodiesIBA 06/2011
1	Toll-Like Receptor 9IBA 12/2010
1	Chemokine ReceptorsIBA 09/2010
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2009
1	Nerve Growth Factors (Neurotrophins)IBA 05/2009
1	Proteins (Proteins, Gene)FDA Link 07/2006
1	Protein AggregatesIBA 07/2006
1	Therapeutic UsesIBA 11/2003
1	Peptides (Polypeptides)IBA 07/2003
1	Amino Acids FDA Link 05/2003
1	Complementary DNA (cDNA)IBA 07/2002

Therapy/Procedure

9	Therapeutics 01/2021 - 05/2003
1	Injections 01/2016
1	Immunomodulation 10/2013
1	Immunotherapy 04/2002